- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 12-01-2026: Press Release
12-01-2026 | 12:10 pm
12-01-2026 | 12:10 pm
Alembic Pharma received USFDA tentative approval for Bosutinib 400 mg tablets, targeting an estimated market of US$ 25.1 Cr. This adds to their 232 cumulative ANDA approvals.
No comments yet. Be the first to comment!